Good medtech/software lead.
More about Sense Biodetection
Sense Biodetection Ltd. is a UK-based molecular diagnostics company founded in 2013 and headquartered in Abingdon, Oxfordshire. The company specializes in developing instrument-free, rapid molecular diagnostic technologies that provide lab-quality results in about 15 minutes. With additional facilities in Cambridge (UK) and Milford, MA (USA), Sense aims to improve healthcare access and decision-making for caregivers and patients through point-of-care testing. The company's core product is the Veros™ Platform, which launched with the Veros COVID-19 test and is expanding to include tests for other infectious diseases. Sense's innovative approach eliminates the need for complex lab instruments, allowing for sensitive nucleic acid detection and immediate treatment decisions. Their technologies are applicable in various sectors, including hospitals, urgent care, and community health, as well as in clinical research and defense. Acquired by Sherlock Biosciences in February 2023, Sense continues to focus on enhancing manufacturing and market reach for its diagnostic solutions.
Live roles
Alert me when Sense Biodetection posts a new role Email me when this changes
Similar Cambridge companies
Full directory →- Genomics plc
Cambridge office (careers page).
- Next Gen Diagnostics (NGD)
Automated sequencing diagnostics.
- Kymab / Sanofi Cambridge 47 live
- AstraZeneca 13 live
Cambridge-headquartered global pharma; major presence at the Cambridge Biomedical Campus. Heavy AI/ML hiring across genetics, drug discovery and biologics engineering.
- GSK 6 live
Global pharma; Stevenage R&D campus is the company's largest UK research site. Active in AI/ML for drug discovery, translational data, and oncology pharmacology.
- Illumina 6 live
Cambridge-based (Chesterford Research Park) arm of Illumina developing DNA sequencing instruments and technology.